Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial

Chidiebere Nwolise; Agata Rembielak; Ray Fitzpatrick; Crispin Jenkinson; Jerry Marsden; Patricia Fairbrother; Charlotte M Proby; Catherine A Harwood; Rubeta N Matin

doi:10.1111/ced.15300

Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial

Chidiebere Nwolise, Agata Rembielak, Ray Fitzpatrick, Crispin Jenkinson, Jerry Marsden, Patricia Fairbrother, Charlotte M Proby, Catherine A Harwood, Rubeta N Matin

Medical Education (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1875-1876
Number of pages	2
Journal	Clinical and Experimental Dermatology
Volume	47
Issue number	10
DOIs	https://doi.org/10.1111/ced.15300
Publication status	Published - Oct 2022

Keywords

Carcinoma, Squamous Cell/pathology
Caregivers
Humans
Radiotherapy, Adjuvant/adverse effects
Retrospective Studies
Skin Neoplasms/pathology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ced.15300

Cite this

Nwolise, C., Rembielak, A., Fitzpatrick, R., Jenkinson, C., Marsden, J., Fairbrother, P., Proby, C. M., Harwood, C. A., & Matin, R. N. (2022). Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial. Clinical and Experimental Dermatology , 47(10), 1875-1876. https://doi.org/10.1111/ced.15300

@article{e3acf909a15e43c883b8171d43cf8580,

title = "Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial",

keywords = "Carcinoma, Squamous Cell/pathology, Caregivers, Humans, Radiotherapy, Adjuvant/adverse effects, Retrospective Studies, Skin Neoplasms/pathology",

author = "Chidiebere Nwolise and Agata Rembielak and Ray Fitzpatrick and Crispin Jenkinson and Jerry Marsden and Patricia Fairbrother and Proby, {Charlotte M} and Harwood, {Catherine A} and Matin, {Rubeta N}",

note = "Funding Information: Acknowledgements: we gratefully acknowledge the Themed Call Funding received from the UK DCTN to carry out this patient and public involvement consultation. The UK DCTN is grateful to the British Association of Dermatologists (BAD) and the University of Nottingham for financial support of the Network.",

year = "2022",

month = oct,

doi = "10.1111/ced.15300",

language = "English",

volume = "47",

pages = "1875--1876",

journal = "Clinical and Experimental Dermatology ",

issn = "0307-6938",

publisher = "John Wiley & Sons Ltd",

number = "10",

}

Nwolise, C, Rembielak, A, Fitzpatrick, R, Jenkinson, C, Marsden, J, Fairbrother, P, Proby, CM, Harwood, CA & Matin, RN 2022, 'Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial', Clinical and Experimental Dermatology , vol. 47, no. 10, pp. 1875-1876. https://doi.org/10.1111/ced.15300

Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial. / Nwolise, Chidiebere; Rembielak, Agata; Fitzpatrick, Ray et al.
In: Clinical and Experimental Dermatology , Vol. 47, No. 10, 10.2022, p. 1875-1876.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER)

T2 - patient and carer views regarding a proposed clinical trial

AU - Nwolise, Chidiebere

AU - Rembielak, Agata

AU - Fitzpatrick, Ray

AU - Jenkinson, Crispin

AU - Marsden, Jerry

AU - Fairbrother, Patricia

AU - Proby, Charlotte M

AU - Harwood, Catherine A

AU - Matin, Rubeta N

N1 - Funding Information: Acknowledgements: we gratefully acknowledge the Themed Call Funding received from the UK DCTN to carry out this patient and public involvement consultation. The UK DCTN is grateful to the British Association of Dermatologists (BAD) and the University of Nottingham for financial support of the Network.

PY - 2022/10

Y1 - 2022/10

KW - Carcinoma, Squamous Cell/pathology

KW - Caregivers

KW - Humans

KW - Radiotherapy, Adjuvant/adverse effects

KW - Retrospective Studies

KW - Skin Neoplasms/pathology

U2 - 10.1111/ced.15300

DO - 10.1111/ced.15300

M3 - Letter

C2 - 35722934

SN - 0307-6938

VL - 47

SP - 1875

EP - 1876

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 10

ER -